Drug Shortage Report for APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Report ID | 68700 |
Drug Identification Number | 02416255 |
Brand name | APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE |
Common or Proper name | ABACAVIR-LAMIVUDINE-ZIDOVUDINE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | ZIDOVUDINE ABACAVIR LAMIVUDINE |
Strength(s) | 300MG 300MG 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60BTL |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-12-03 |
Estimated end date | Unknown |
Actual end date | 2022-12-02 |
Shortage status | Resolved |
Updated date | 2022-12-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-12-13 | French | Compare |
v9 | 2022-12-13 | English | Compare |
v8 | 2020-06-15 | French | Compare |
v7 | 2020-06-15 | English | Compare |
v6 | 2020-04-27 | French | Compare |
v5 | 2020-04-27 | English | Compare |
v4 | 2019-03-15 | French | Compare |
v3 | 2019-03-15 | English | Compare |
v2 | 2018-12-05 | French | Compare |
v1 | 2018-12-05 | English | Compare |
Showing 1 to 10 of 10